Bayer Ascensia recall marked "class I"
This article was originally published in Clinica
The FDA has slapped a class 1 label - the most serious category - on Bayer Healthcare's recall of its Ascensia Contour blood glucose monitoring system. The company initiated the recall after discovering 16 of the glucose meters, distributed in Canada, had not been adjusted to display the correct measure for Canadian users.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.